Imperial College London
π§πͺBelgium
- Country
- π§πͺBelgium
- Ownership
- Private
- Established
- 1907-07-08
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.imperial.ac.uk
Mechanisms of Multi-organ Failure in COVID-19
- First Posted Date
- 2020-05-22
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 120
- Registration Number
- NCT04399603
- Locations
- π¬π§
Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom
π¬π§Imperial College NHS Trust, London, United Kingdom
COVID-19 and Cancer Patients
- First Posted Date
- 2020-05-19
- Last Posted Date
- 2022-07-15
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 1000
- Registration Number
- NCT04393974
- Locations
- π¬π§
Imperial College Healthcare NHS Trust, London, United Kingdom
TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-04-27
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 24
- Registration Number
- NCT04362436
- Locations
- π¬π§
Imperial College NHS Trust, London, United Kingdom
Itacitinib in Advanced Hepatocellular Carcinoma
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2023-02-14
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 24
- Registration Number
- NCT04358185
- Locations
- π¬π§
Imperial College Healthcare NHS Trust, London, United Kingdom
Axitinib Monotherapy With Early Dynamic Contrast Enhanced Ultrasound Monitoring in Chemorefractory Third Line Metastatic Colorectal Cancer
- First Posted Date
- 2020-04-21
- Last Posted Date
- 2020-04-21
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 52
- Registration Number
- NCT04355156
- Locations
- π¬π§
Imperial College Healthcare NHS Trust, London, United Kingdom
Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus)
Completed
- Conditions
- First Posted Date
- 2020-04-07
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 15
- Registration Number
- NCT04337489
- Locations
- π¬π§
Imperial College London, London, United Kingdom
Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2020-04-03
- Last Posted Date
- 2023-01-18
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 320
- Registration Number
- NCT04333407
- Locations
- π¬π§
Charing Cross Hospital, London, United Kingdom
A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-03-24
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 72
- Registration Number
- NCT04319367
- Locations
- π¬π§
Manchester University NHS Foundation Trust, Manchester, United Kingdom
π¬π§Barts Health NHS Trust, London, United Kingdom
π©π°Aarhus University Hospital, Aarhus, Denmark
The Evaluation of Tomographic 3D Ultrasound for the Assessment of Vascular Pathology
- First Posted Date
- 2020-03-23
- Last Posted Date
- 2023-01-25
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 75
- Registration Number
- NCT04318171
- Locations
- π¬π§
Imperial College London, London, United Kingdom
Smart Catheter: A Novel Biosensor for Early Detection of Catheter Associated Urinary Tract Infection
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-03-19
- Last Posted Date
- 2021-09-02
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 100
- Registration Number
- NCT04315129
- Locations
- π¬π§
St Mary's Hospital, London, Greater LOndon, United Kingdom
Β© Copyright 2024. All Rights Reserved by MedPath